RUFINAMIDE

Generic: RUFINAMIDE

Glenmark Pharmaceuticals Inc.Manufacturer
ORALRoute
RUFINAMIDEActive Substance
2016-05-16Original Approval

RUFINAMIDE is FDA application ANDA205075, sponsored by GLENMARK PHARMS LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DRUG INEFFECTIVE
269 reports
2
SEIZURE
252 reports
3
OFF LABEL USE
196 reports
4
SOMNOLENCE
101 reports
5
CONDITION AGGRAVATED
88 reports
6
MULTIPLE-DRUG RESISTANCE
85 reports
7
DRUG INTERACTION
77 reports
8
EPILEPSY
69 reports
9
TREATMENT FAILURE
57 reports
10
HOSPITALISATION
51 reports